115 related articles for article (PubMed ID: 7982228)
1. Inhibition of bacterial and viral sialidases by 3-fluoro-N-acetylneuraminic acid.
Hagiwara T; Kijima-Suda I; Ido T; Ohrui H; Tomita K
Carbohydr Res; 1994 Oct; 263(1):167-72. PubMed ID: 7982228
[No Abstract] [Full Text] [Related]
2. Slow-binding inhibition of sialidase from influenza virus.
Pegg MS; von Itzstein M
Biochem Mol Biol Int; 1994 Apr; 32(5):851-8. PubMed ID: 8069234
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of sialidases from viral, bacterial and mammalian sources by analogues of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid modified at the C-4 position.
Holzer CT; von Itzstein M; Jin B; Pegg MS; Stewart WP; Wu WY
Glycoconj J; 1993 Feb; 10(1):40-4. PubMed ID: 8358225
[TBL] [Abstract][Full Text] [Related]
4. Aromatic sialic acid analogues as potential inhibitors of influenza virus neuraminidase.
Bianco A; Brufani M; Melchioni C
Farmaco; 2001 Apr; 56(4):305-9. PubMed ID: 11421259
[TBL] [Abstract][Full Text] [Related]
5. A novel synthetic reversible inhibitor of sialidase efficiently blocks secondary but not primary influenza virus infection of MDCK cells in culture.
Barrère B; Driguez PA; Maudrin J; Doutheau A; Aymard M; Quash G
Arch Virol; 1997; 142(7):1365-80. PubMed ID: 9267449
[TBL] [Abstract][Full Text] [Related]
6. A novel means of identifying the neuraminidase type of currently circulating human A(H1) influenza viruses.
Hurt AC; Barr IG; Komadina N; Hampson AW
Virus Res; 2004 Jul; 103(1-2):79-83. PubMed ID: 15163493
[TBL] [Abstract][Full Text] [Related]
7. Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 1. Discovery, synthesis, biological activity, and structure-activity relationships of 4-guanidino- and 4-amino-4H-pyran-6-carboxamides.
Smith PW; Sollis SL; Howes PD; Cherry PC; Starkey ID; Cobley KN; Weston H; Scicinski J; Merritt A; Whittington A; Wyatt P; Taylor N; Green D; Bethell R; Madar S; Fenton RJ; Morley PJ; Pateman T; Beresford A
J Med Chem; 1998 Mar; 41(6):787-97. PubMed ID: 9526555
[TBL] [Abstract][Full Text] [Related]
8. Zanamivir. A potent and selective inhibitor of influenza A and B viruses.
Aoki FY; Hayden FG
Clin Pharmacokinet; 1999; 36 Suppl 1():v-ix. PubMed ID: 10429834
[No Abstract] [Full Text] [Related]
9. Mutations affecting the sensitivity of the influenza virus neuraminidase to 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid.
Goto H; Bethell RC; Kawaoka Y
Virology; 1997 Nov; 238(2):265-72. PubMed ID: 9400599
[TBL] [Abstract][Full Text] [Related]
10. Highly potent and long-acting trimeric and tetrameric inhibitors of influenza virus neuraminidase.
Watson KG; Cameron R; Fenton RJ; Gower D; Hamilton S; Jin B; Krippner GY; Luttick A; McConnell D; MacDonald SJ; Mason AM; Nguyen V; Tucker SP; Wu WY
Bioorg Med Chem Lett; 2004 Mar; 14(6):1589-92. PubMed ID: 15006410
[TBL] [Abstract][Full Text] [Related]
11. Sialoglycoproteins that bind influenza A virus and resist viral neuraminidase in different animal sera.
Suzuki T; Tsukimoto M; Kobayashi M; Yamada A; Kawaoka Y; Webster RG; Suzuki Y
J Gen Virol; 1994 Jul; 75 ( Pt 7)():1769-74. PubMed ID: 7517433
[TBL] [Abstract][Full Text] [Related]
12. Generation and characterization of an influenza virus neuraminidase variant with decreased sensitivity to the neuraminidase-specific inhibitor 4-guanidino-Neu5Ac2en.
Blick TJ; Tiong T; Sahasrabudhe A; Varghese JN; Colman PM; Hart GJ; Bethell RC; McKimm-Breschkin JL
Virology; 1995 Dec; 214(2):475-84. PubMed ID: 8553549
[TBL] [Abstract][Full Text] [Related]
13. [Antiviral agents for influenza].
Mitamura K
Nihon Rinsho; 2003 Feb; 61 Suppl 2():798-803. PubMed ID: 12722319
[No Abstract] [Full Text] [Related]
14. Design of N-acetyl-6-sulfo-beta-d-glucosaminide-based inhibitors of influenza virus sialidase.
Sasaki K; Nishida Y; Kambara M; Uzawa H; Takahashi T; Suzuki T; Suzuki Y; Kobayashi K
Bioorg Med Chem; 2004 Mar; 12(6):1367-75. PubMed ID: 15018909
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic drug susceptibility assay for influenza virus neuraminidase inhibitors.
McSharry JJ; McDonough AC; Olson BA; Drusano GL
Clin Diagn Lab Immunol; 2004 Jan; 11(1):21-8. PubMed ID: 14715540
[TBL] [Abstract][Full Text] [Related]
16. Utilization of the embryonated egg for in vivo evaluation of the anti-influenza virus activity of neuraminidase inhibitors.
Sauerbrei A; Haertl A; Brandstaedt A; Schmidtke M; Wutzler P
Med Microbiol Immunol; 2006 Jun; 195(2):65-71. PubMed ID: 16059699
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis for the resistance of influenza viruses to 4-guanidino-Neu5Ac2en.
Staschke KA; Colacino JM; Baxter AJ; Air GM; Bansal A; Hornback WJ; Munroe JE; Laver WG
Virology; 1995 Dec; 214(2):642-6. PubMed ID: 8553569
[TBL] [Abstract][Full Text] [Related]
18. Genetic analysis reveals that both haemagglutinin and neuraminidase determine the sensitivity of naturally occurring avian influenza viruses to zanamivir in vitro.
Baigent SJ; Bethell RC; McCauley JW
Virology; 1999 Oct; 263(2):323-38. PubMed ID: 10544106
[TBL] [Abstract][Full Text] [Related]
19. Neuraminidase inhibitors as antivirals.
Colman PM
Vaccine; 2002 May; 20 Suppl 2():S55-8. PubMed ID: 12110259
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of replication of avian influenza viruses by the neuraminidase inhibitor 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid.
Gubareva LV; Penn CR; Webster RG
Virology; 1995 Oct; 212(2):323-30. PubMed ID: 7571401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
